The a2 Milk Company (a2MC) has signed an exclusive sales and distribution agreement with South Korean pharmaceutical company Yuhan Corporation.
This agreement gives Yuhan Corporation the right to promote and distribute a2MC’s branded products throughout South Korea.
a2MC claims that South Korea was an attractive market for the company, due to the country’s high per-capita dairy consumption rates, strong retail market and growing e-Commerce channel.
Initial sales of a2 Milk products are expected to begin in the second half of 2018, and products will be sourced from a2’s production sites in Australia and New Zealand.
Nutritional products for the South Korean market will be produced by a2MC’s supply partner Synlait Milk.
Managing Director & CEO of The a2 Milk Company, Geoffrey Babidge said: “Yuhan Corporation is a long established, highly credentialed and principled Korean business.
“We share similar values and ambitions, and with our complimentary capabilities believe that together we can build a meaningful business in South Korea.”
Lee Junghee, CEO and president of Yuhan Corporation added: “Aligning both our companies’ histories and values to promote growth through continuous research and innovation, Yuhan Corporation and The a2 Milk Company will together launch a range of dairy nutritional products with only the A2 beta-casein protein type that Koreans can consume for their health and well-being.”
© FoodBev Media Ltd 2019
World Beverage Innovation Awards – ENTER NOW!
The awards celebrate excellence and innovation across the global beverage industry.
Don’t miss out on having your innovations recognised on a global scale.